Gamolenic acid

加莫烯酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGamolenic acid
Drug Alias Name全顺十八碳-6,9,12-三烯酸Acidum gamolenicumEfamastEpogam
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDermatitis, AtopicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesScotia
Active IndicationsDermatitis, Atopic
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeD11AX02
Related LinksWikipediaKEGG